Dong HL - Search Results

1

[Prediction synthesis and identification of HLA-A2-restricted cytotoxic T lymphocyte epitopes of the tumor antigen MAGE-n].

Dong HL, Sui YF, Ye J, Li ZS, Qu P, Zhang XM, Chen GS, Lu SY. Dong HL, et al. Zhonghua Yi Xue Za Zhi. 2003 Jun 25;83(12):1080-3. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899783 Chinese.

2

[Establishment of a human cervical carcinoma cell line HCC-0214 and its biological characteristics].

Dong HL, Sui YF, Qu P, Li ZS, Lu SY, Zhang SZ, Ye J, Chen GS. Dong HL, et al. Zhonghua Zhong Liu Za Zhi. 2003 Jan;25(1):43-6. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 12678986 Chinese.

3

[Targeted tumor suppression by a secreted fusion protein consisting of anti- erbB2 antibody and reversed caspase-3 to SKBr3 cells].

Zhang LH, Jia LT, Yu CJ, Qu P, Dong HL, Zhao J, Xu YM, Wang CJ, Yang AG. Zhang LH, et al. Among authors: dong hl. Zhonghua Yi Xue Za Zhi. 2003 Apr 10;83(7):564-8. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12887745 Chinese.

4

Superantigen-SEA gene modified tumor vaccine for hepatocellular carcinoma: an in vitro study.

Lu SY, Sui YF, Li ZS, Ye J, Dong HL, Qu P, Zhang XM, Wang WY, Li YS. Lu SY, et al. Among authors: dong hl. World J Gastroenterol. 2004 Jan;10(1):53-7. doi: 10.3748/wjg.v10.i1.53. World J Gastroenterol. 2004. PMID: 14695768 Free PMC article.

5

In vivo tumor co-transfection with superantigen and CD80 induces systemic immunity without tolerance and prolongs survival in mice with hepatocellular carcinoma.

Li ZS, Yang XW, Chen Z, Dong HL, Ye J, Qu P, Lu SY, Zhang XM, Sui YF. Li ZS, et al. Among authors: dong hl. Cancer Biol Ther. 2004 Jul;3(7):660-6. doi: 10.4161/cbt.3.7.920. Epub 2004 Jul 9. Cancer Biol Ther. 2004. PMID: 15136758 Free article.

6

[Study on immunoreaction induced by DCs loaded with hepatocarcinoma antigen peptide in-vitro].

Qu P, Sui YF, Guo AL, Cao YX, Dong HL, Lu SY, Ye J, Zhang XM. Qu P, et al. Among authors: dong hl. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jul;19(4):406-8. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003. PMID: 15163400 Chinese.

7

Efficient induction of cytotoxic T lymphocytes specific to hepatocellular carcinoma using HLA-A2-restricted MAGE-n peptide in vitro.

Dong HL, Sui YF, Li ZS, Qu P, Wu W, Ye J, Zhang XM, Lu SY. Dong HL, et al. Cancer Lett. 2004 Aug 10;211(2):219-25. doi: 10.1016/j.canlet.2004.02.013. Cancer Lett. 2004. PMID: 15219945

8

Identification of HLA-A2-restricted CTL epitope encoded by the MAGE-n gene of human hepatocellular carcinoma.

Dong HL, Li ZS, Ye J, Qu P, Huang YY, Wu W, Lu SY, Chen GS, Sui YF. Dong HL, et al. Cancer Biol Ther. 2004 Sep;3(9):891-8. doi: 10.4161/cbt.3.9.1081. Epub 2004 Sep 15. Cancer Biol Ther. 2004. PMID: 15326372 Free article.

9

Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method.

Dong HL, Sui YF. Dong HL, et al. World J Gastroenterol. 2005 Jan 14;11(2):208-11. doi: 10.3748/wjg.v11.i2.208. World J Gastroenterol. 2005. PMID: 15633217 Free PMC article.

10

[Ischemic postconditioning induces neuroprotection via up-regulation of endogenous antioxidant enzyme activities: experiment with rabbits].

Song WY, Dong HL, Cheng Q, Lu ZH, Wang H, Meng JR, Xiong LZ. Song WY, et al. Among authors: dong hl. Zhonghua Yi Xue Za Zhi. 2008 Aug 26;88(33):2355-9. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19087700 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters